Cargando…
Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?
Genomic data from breast cancers provide additional prognostic and predictive information that is beginning to be used for patient management. The question arises whether additional information derived from other 'omic' approaches such as metabolomics can provide additional information. In...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995773/ https://www.ncbi.nlm.nih.gov/pubmed/21080936 http://dx.doi.org/10.1186/1741-7015-8-73 |